drugset / Trial / NCT01118780

A Study of Duloxetine in Elderly Generalized Anxiety Disorder

NCT01118780 ↗

Phase 4 Completed 291 enrolled Eli Lilly and Company
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to test the safety and efficacy of duloxetine versus placebo in elderly patients suffering from generalized anxiety disorder (GAD).

Timeline

Start
2010-10
Primary completion
2012-07
Completion
2012-07

Outcome

Met primary endpoint

registry analysis (superiority or other test); Duloxetine vs Placebo; p <0.001; LS mean difference 4.17 (95% CI 2.47 to 5.88); Mixed Models Analysis NCT01118780 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Duloxetine Small molecule 30 mg Oral
Subject Duloxetine Small molecule 120 mg Oral